Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating milademetan alone and with 5-azacitidine in acute myeloid leukemia or high-risk myelodysplastic syndrome; study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• 5-Azacitidine (azacitidine)
• Milademetan (milademetan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED | Results posted: 2021-10-11